⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3261233 | 0.81 | — | — | |
| SCHEMBL950801 | 0.77 | — | — | |
| SCHEMBL102100 | 0.77 | — | — | |
| SCHEMBL19193443 | 0.76 | TYR (0.32) | — | |
| SCHEMBL4911960 | 0.75 | — | — | |
| SCHEMBL18724628 | 0.75 | — | — | |
| SCHEMBL13924050 | 0.75 | — | — | |
| SCHEMBL3697627 | 0.75 | — | — | |
| SCHEMBL5301874 | 0.75 | — | — | |
| SCHEMBL878799 | 0.73 | ALDH1A1 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 891 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117038912-B | Positive electrode material, preparation method thereof and battery | 蜂巢能源科技股份有限公司 | 2024-12-27 | — | — | CN | claimed |
| CN-117038905-A | Composite manganese-based positive electrode material, preparation method thereof and lithium ion battery | 蜂巢能源科技股份有限公司 | 2023-11-10 | — | — | CN | claimed |
| CN-117038912-A | Positive electrode material, preparation method thereof and battery | 蜂巢能源科技股份有限公司 | 2023-11-10 | — | — | CN | claimed |
| CN-110204539-B | Dihydropyrimidine prodrug and preparation method and application thereof | 山东大学 | 2021-07-23 | — | — | CN | claimed |
| CN-112745290-A | Method for synthesizing 4-bromomethyl-5-methyl-1, 3-dioxole-2-one under catalysis of microwave and ionic liquid | 山东金城柯瑞化学有限公司 | 2021-05-04 | — | — | CN | claimed |
| US-8501741-B2 | Optically active compound of prulifloxacin for treating infection and preparation method thereof | HAINAN HUALON PHARMACEUTICAL CO., LTD. (CN) | 2013-08-06 | — | — | US | claimed |
| US-20120302580-A1 | OPTICALLY ACTIVE COMPOUND OF PRULIFLOXACIN FOR TREATING INFECTION AND PREPARATION METHOD THEREOF | HAINAH HUALON PHARMACEUTICAL CO., LTD. (CN) | 2012-11-29 | — | — | US | claimed |
| EP-2524922-A1 | OPTICALLY ACTIVE COMPOUND OF PRULIFLOXACIN FOR TREATING INFECTION AND PREPARATION METHOD THEREOF | Hainan Hualon Pharmaceutical Co., Ltd. (CN) | 2012-11-21 | — | — | EP | claimed |
| WO-2012001357-A1 | CRYSTALLINE FORM OF PRULIFLOXACIN AND PROCESSES FOR ITS PREPARATION | CIPLA LIMITED (IN) | 2012-01-05 | — | — | WO | claimed |
| US-4935508-A | Acylation of 7-aminocephalosporin with alkyl 2-(2-amino-thiazol-4-yl)-2-oximinoacetate | BRISTOL-MYERS COMPANY (US) | 1990-06-19 | — | — | US | claimed |
| EP-0237084-A2 | 4-Bromomethyl-5-methyl-1,3-dioxolen-2-one, and a process for the production thereof | KANEBO, LTD. (JP) | 1987-09-16 | — | — | EP | claimed |
| EP-0039477-B1 | USE OF 1,3-DIOXOLEN-2-ONE DERIVATIVES | KANEBO, LTD. (JP) | 1984-12-27 | — | — | EP | claimed |
| EP-0090344-A1 | 1,3-Dioxolen-2-one derivatives and process for production thereof | KANEBO, LTD. (JP) | 1983-10-05 | — | — | EP | claimed |
| US-4342693-A | USED FOR INTRODUCING PROTECTIVE GROUPS ON PHARMECUTICALS AND OTHERS | KANEBO LTD. (JP) | 1982-08-03 | — | — | US | claimed |
| EP-0039477-A1 | Use of 1,3-Dioxolen-2-one derivatives | KANEBO, LTD. (JP) | 1981-11-11 | — | — | EP | claimed |
| JP-59212488-A | — | — | None | — | — | JP | disclosed |
| JP-59021692-A | — | — | None | — | — | JP | disclosed |
| US-4342693-A | USED FOR INTRODUCING PROTECTIVE GROUPS ON PHARMECUTICALS AND OTHERS | KANEBO LTD. (JP) | 1982-08-03 | — | — | US | disclosed |
| EP-0039477-A1 | Use of 1,3-Dioxolen-2-one derivatives | KANEBO, LTD. (JP) | 1981-11-11 | — | — | EP | disclosed |
| EP-0039086-A2 | Novel ampicillin esters and production thereof | KANEBO, LTD. (JP) | 1981-11-04 | — | — | EP | disclosed |